Latest Blogs

Nov 20, 2018
 Although there are still several weeks left in 2018, events have left me speechless twice this year: the deaths of two women, well before their time.
Nov 20, 2018
Attending the ASCO Annual Meeting was a great reminder of the importance of our social media-based networking; each time I “met” a HOWPG member for the first time, it felt like meeting a close old friend.
Nov 20, 2018
To rescue someone on the precipice takes courage, with strong doses of love, acceptance, and supported choices and, above all, trust and hopefulness.
Nov 19, 2018
At a recent meeting, the ASCO delegation to the AMA House of Delegates presented concerns focused on the Competitive Acquisition Program (CAP), among a variety of other issues.
Subscribe to this column

Clifford A. Hudis, MD, FACP, FASCO

Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO. Prior to this role, he served as Chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a Past President of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to the obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.

Jul 09, 2018
I am really pleased to have with us ASCO's Chief Medical Officer and Senior Vice President for a conversation focusing on right-to-try policies.
Jun 29, 2018
At the most recent Board of Directors meeting, we heard insightful presentations from participants in the Leadership Development Program, pivoted toward the execution of our 5-year strategic plan, and had a valuable conversation with NCI director Dr. Norman Sharpless.
May 24, 2018
While more biosimilars will likely be available in oncology in the next several years, their specific impact on patient care is going to depend on patient and provider acceptance of these agents.
May 17, 2018
ASCO would like to inform you of some changes to MOC that are a direct result of your input and our open, transparent collaboration with the ABIM. 
May 08, 2018
We examine how state-level health care policy may impact the care that we deliver to our patients with cancer, and why it's important for us to pay attention to and help shape bills and regulations moving in states.
Apr 06, 2018
Our vice president of Clinical Affairs breaks down the reporting changes you need to understand and address to avoid potential financial penalties in 2020.

Pages